Pfizer Rejects US For Extra Supply of COVID-19 Vaccine Doses
Pfizer pharmaceutical company, one of the main distributors of Coronavirus vaccines in the world, has decided to turn down US for extra supply of COVID-19 vaccines. This medicine is one of the most sought-after vaccines in the world, after company claimed it having 90% effectivity against the virus.
Meanwhile, in a different report, Pfizer-- joined with Moderna-- will no longer attend the country's 'vaccine summit,'happening on Tuesday, Dec. 8. Why is this happening?
When will the Coronavirus vaccine arrive in the US?
Nurses at the Royal Free Hospital, London, simulate the administration of the Pfizer vaccine to support staff training ahead of the rollout, on December 5, 2020 in London, England.
On Monday, Dec. 7, the New York Times reported that the Pfizer company has rejected the idea of buying too much vaccine per country.
In a statement, the company said that they will not entertain any additional vaccine doses, even by request of the government. For example, in the US, the initial 100 million doses won't have extended number anymore.
According to Pfizer, "any additional doses beyond the 100 million are subject to a separate and mutually acceptable agreement," and that "the company is not able to comment on any confidential discussions that may be taking place with the U.S. government."
This also means that the company won't be able to support and provide vaccine to the country until next June. As explained by them, a lot of countries are now looking for their company to supply for vaccine-- resulting to a stringent supply for all.
There's nothing to worry about
Though the company has not promised a sufficient supply for the US, the federal government said that they're confident to provide vaccine to all Americans in the country.
Apart from Pfizer, the US also find other vaccine sources.
"We are confident that we will have 100 million doses of Pfizer's vacine as agreed to in our contract, and beyond that, we have five other vaccine candidates."
Pfizer and Moderna turned down 'vaccine summit'
A medical worker administers a Flu vaccination during a free flu clinic vaccination event held by Meijer at Comerica Park on November 10, 2020 in Detroit, Michigan. With Covid-19 cases skyrocketing around the US medical professionals fear that a bad flu season will only make things worse and further fill hospitals and deplete medical supplies around the nation.
Aside from Pfizer stating fixed amount of vaccine supply for every country, a new report also said that Pfizer and even Moderna-- another producer of COVID-19 vaccine-- will not attend the government's scheduled 'vaccine summit.'
According to an Independent report, Albert Bourla, CEO of Pfizer, and Stéphane Bancel, CEO of Moderna, will no longer attend the event.
Both of the companies have not expressed the reason behind the sudden decision.
RELATED ARTICLE: New CRISPR-Based COVID-19 Diagnosis Technique, Utilizes Smartphone Camera
Dec 07, 2020 08:55 PM EST
